Stay updated on Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial
Sign up to get notified when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page.

Latest updates to the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedA new Revision: v3.6.6 entry was added to the version history, and the previous Revision: v3.6.5 entry was removed. This reflects an update to the page metadata rather than substantive trial data.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe record history shows a new revision entry updating from v3.6.4 to v3.6.5, indicating a metadata update to the ClinicalTrials.gov record. This change reflects an administrative update rather than new or modified trial data.SummaryDifference0.1%

- Check54 days agoChange DetectedThe latest revision entry (v3.6.4) was added to the study history, and the previous revision (v3.6.3) was removed.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision updated to v3.6.3, replacing the previous v3.6.2. This reflects a new iteration of the study record rather than a substantive change to page content.SummaryDifference0.1%

- Check82 days agoChange DetectedRevision: v3.6.2 was added in the page footer, replacing the previous v3.6.0 label, indicating a software version update rather than a content change.SummaryDifference0.1%

- Check97 days agoChange DetectedRecruitment is no longer looking for participants. The record has been updated to revision v3.6.0, replacing the previous revision v3.5.5.SummaryDifference0.4%

Stay in the know with updates to Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carboplatin-Paclitaxel/Pembrolizumab in Squamous NSCLC Clinical Trial page.